Transcriptional analysis of pluripotency reveals the Hippo pathway as a barrier to reprogramming.
Ontology highlight
ABSTRACT: Pluripotent stem cells are derived from culture of early embryos or the germline and can be induced by reprogramming of somatic cells. Barriers to reprogramming that stabilize the differentiated state and have tumor suppression functions are expected to exist. However, we have a limited understanding of what such barriers might be. To find novel barriers to reprogramming to pluripotency, we compared the transcriptional profiles of the mouse germline with pluripotent and somatic cells, in vivo and in vitro. There is a remarkable global expression of the transcriptional program for pluripotency in primordial germ cells (PGCs). We identify parallels between PGC reprogramming to pluripotency and human germ cell tumorigenesis, including the loss of LATS2, a tumor suppressor kinase of the Hippo
SUBMITTER: Qin H
PROVIDER: S-EPMC3315209 | biostudies-literature | 2012 May
REPOSITORIES: biostudies-literature
ACCESS DATA